2021-01-30 5. 城上城行政中心2F 第三會議室
| 時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
|---|---|---|---|---|---|
11:00 ~ 11:10 |
PD02-1: Modified dual time point 18F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma |
黃昭淵, 黃志平 |
|||
11:10 ~ 11:20 |
PD02-2: MRE11 expression level predicts poor survival in upper tract urothelial carcinomas |
詹鎮豪 |
黃昭淵, 黃志平 |
||
11:20 ~ 11:30 |
PD02-3: Determination of PD-L1 expression in circulating tumor cells of clear cell renal cell carcinoma patients and correlation with response to PD-1 inhibitors |
黃昭淵, 黃志平 |
|||
11:30 ~ 11:40 |
PD02-4: Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) in metastatic prostate cancer (PCa) |
黃昭淵, 黃志平 |
|||
11:40 ~ 11:50 |
PD02-5: Metformin may impact overall survival of upper tract urothelial carcinoma in patients with type 2 diabetes |
黃昭淵, 黃志平 |
|||
11:50 ~ 12:00 |
PD02-6: Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: Single-center analysis of predictive factors |
黃昭淵, 黃志平 |